Advertisement
News
Subscribe to MDT Magazine News

Mindray Medical to Present at the 14th Annual Credit Suisse Asian Investment Conference on March 21-25

March 11, 2011 3:33 am | by Bio-Medicine.Org | Comments

SHENZHEN, China, March 11, 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR ), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will present at the 14th Annual Credit Suisse Asian Investment Conference,...

TOPICS:

Simple blood test detects early emphysema in smokers before symptoms appear

March 10, 2011 8:33 pm | by EurekAlert | Comments

(New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College) During a regular annual physical exam, blood is usually drawn to check the health of a person's heart, kidneys and liver. Now, researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical...

TOPICS:

Colibrys SA strengthens its presence in China

March 10, 2011 7:36 pm | by I-Micronews | Comments

Neuchatel, Switzerland: Colibrys signed today an agency agreement with NAV Technology Co., Ltd. based in Beijing, China for its MEMS accelerometers within China.

Advertisement

Valeant Pharmaceuticals Completes Acquisition of PharmaSwiss S.A.

March 10, 2011 7:33 pm | by Bio-Medicine.Org | Comments

MISSISSAUGA, Ontario, March 11, 2011 /- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX: VRX) announced that effective March 10, 2011, the company completed its previously announced acquisition of PharmaSwiss S.A. About Valeant Valeant Pharmaceuticals International, Inc....

TOPICS:

Emergent BioSolutions 4Q profit surges on BioThrax

March 10, 2011 1:45 pm | by The Associated Press | Comments

Emergent BioSolutions Inc. said Thursday its fourth-quarter profit surged on sales of its anthrax treatment BioThrax.The company earned $26.2 million, or 76 cents per share, compared with $4.2 million, or 13 cents per share, during the same period a year prior. Revenue nearly doubled to $103.2...

Given Imaging gets expanded approval for PillCam

March 10, 2011 12:45 pm | by The Associated Press | Comments

Given Imaging Ltd., an Israeli maker of pill-sized diagnostic cameras, said Thursday its swallowable PillCam camera received expanded Food and Drug Administration approval.The device was already approved for use in colonoscopies and other procedures. It is now approved for monitoring lesions that...

Brain cell regrowth linked to benefits of exercise, sexual behaviors and reproductive issues

March 10, 2011 12:37 pm | by EurekAlert | Comments

(Cell Transplantation Center of Excellence for Aging and Brain Repair) Recent research confirms that adult brain cells can regenerate. Two studies explore links between neurogenesis of key adult brain cells in two critical areas of the brain -- the hippocampus and subventricular...

TOPICS:

Trapping prostate cancer cells to keep them from spreading provides hope

March 10, 2011 12:37 pm | by EurekAlert | Comments

(Cell Transplantation Center of Excellence for Aging and Brain Repair) When prostate cancer stem cells (CSCs) were enclosed in self-assembling nanomaterials made of peptides (SAP), the SAPs stopped cancer stem cell colony formation and also stopped the division of cancer cells in...

TOPICS:
Advertisement

'Probiotics and Health Claims'

March 10, 2011 10:37 am | by EurekAlert | Comments

(Wiley-Blackwell) New title explores the scientific basis for the health benefits of "friendly bacteria" and how those claims are regulated.

TOPICS:

Vertex plans to grow epilepsy drug trial

March 10, 2011 9:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Vertex Pharmaceuticals Inc. said it will conduct a broader trial of a potential drug against epilepsy following positive results in a Phase 2 study.

Avaxia gets SBIR grant to fight celiac disease

March 10, 2011 9:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Avaxia Biologics Inc. has won a Phase 1 Small Business Innovation Research (SBIR) grant from the National Institutes of Health to develop a new antibody therapeutic for celiac disease that can be taken orally.

MLSC invites pitches for capital projects funding

March 10, 2011 9:38 am | by Mass High Tech: The Journal of New England Technology | Comments

The Massachusetts Life Sciences Center today announced open solicitations for investment requests relating to life sciences-related capital projects beginning in Fiscal Year 2013.

Dendreon Expands Launch of PROVENGE

March 10, 2011 9:37 am | by Bio-Medicine.Org | Comments

SEATTLE, March 10, 2011 /- Dendreon Corporation (Nasdaq: DNDN ) announced today that the U.S. Food and Drug Administration (FDA) approved the remainder of its New Jersey manufacturing facility, allowing the company to significantly increase the availability of PROVENGE®...

TOPICS:

International Prostate Cancer Treatment Expert Dr. David B. Samadi Supports Kenyan Minister of Medical Services, Peter Anyang Nyong'o's Decision to Travel to the U.S. for Pros...

March 10, 2011 9:36 am | by Bio-Medicine.Org | Comments

NEW YORK, March 10, 2011 /- Last Saturday, Kenyan Minister of Medical Services Peter Anyang Nyong'o stepped off a plane and onto Kenyan soil to a hero's welcome.  His return marked the end of a nearly year long struggle with prostate cancer.  Having been met with the harsh...

TOPICS:

Innovations That Could Change the Way We Manufacture

March 10, 2011 7:37 am | by Society of Manufacturing Engineers | Comments

DEARBORN, Mich., March 10, 2011 — Honoring both innovation and manufacturing, the Society of Manufacturing Engineers (SME) today announced the 2011 list of Innovations That Could Change The Way You Manufacture. More

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading